Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
Randomized Pilot Trial of Omega-3 Fatty Acids or Placebo in Peri- or Post-Menopausal Women at High Risk for Breast Cancer Undergoing a Weight Loss Intervention
Sponsor: Carol Fabian, MD
Listed as NCT02101970, this NA trial focuses on Breast Cancer and remains completed. Sponsored by Carol Fabian, MD, it has been updated 10 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Mar 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Mar 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Feb 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Carol Fabian, MD
- dsm-firmenich Switzerland AG
For direct contact, visit the study record on ClinicalTrials.gov .